Literature DB >> 11815758

Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings.

Ralf G Heine1, Donald J s Cameron, Chung W Chow, David J Hill, Anthony G Catto-Smith.   

Abstract

OBJECTIVES: Our purpose was to study the relation between gastroesophageal reflux (GER) and esophagitis in infants with persistent distress. STUDY
DESIGN: Infants (n = 125, 79 boys; median age, 4.2 months) with persistent distress and clinical symptoms suggestive of GER and esophagitis were retrospectively studied. All had undergone esophageal 24-hour pH monitoring and had upper gastrointestinal biopsy specimens taken.
RESULTS: There were 65 (48%) infants with inflammatory changes found in at least one upper gastrointestinal biopsy specimen, of whom 32 (25.6%) had esophagitis; 11 infants with esophagitis also had gastritis or duodenitis. Although infants with frequent regurgitation (n = 65) had significantly more frequent GER episodes per 24 hours (P <.03) and greater fractional reflux time (P <.001) than infants without, this was not associated with histologic esophagitis (P =.33). Of the 32 infants with esophagitis, 9 had abnormal pH monitoring and 23 had nonreflux esophagitis. A separate group of 23 infants had abnormal pH monitoring but no esophagitis. Diagnostic agreement between pH monitoring and esophageal histologic features was poor (kappa = 0.07).
CONCLUSION: Esophagitis occurred in one quarter of infants with persistent distress. Abnormal esophageal pH monitoring did not reliably predict esophagitis, suggesting a nonacid peptic cause in some of these infants.

Entities:  

Mesh:

Year:  2002        PMID: 11815758     DOI: 10.1067/mpd.2002.120695

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

Review 1.  GERD in the pediatric patient: management considerations.

Authors:  David A Gremse
Journal:  MedGenMed       Date:  2004-05-05

Review 2.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

3.  Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children.

Authors:  Eric Chiou; Rachel Rosen; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-04       Impact factor: 2.839

Review 4.  Gastroesophageal reflux disease in neonates and infants : when and how to treat.

Authors:  Steven J Czinn; Samra Blanchard
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 5.  Clinical spectrum of food allergies: a comprehensive review.

Authors:  Marco H-K Ho; Wilfred H-S Wong; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 6.  Food allergies.

Authors:  Paula F G O'Leary; Fergus Shanahan
Journal:  Curr Gastroenterol Rep       Date:  2002-10

7.  Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole.

Authors:  Elizabet V Guimarães; Paula Vp Guerra; Francisco J Penna
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

8.  Oesophageal pH monitoring and reflux oesophagitis in irritable infants.

Authors:  Yvan Vandenplas; Hegar Badriul; Marc Verghote; Bruno Hauser; Leonard Kaufman
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

9.  Endoscopic and histopathologic findings associated with H. pylori infection in very young children.

Authors:  Engin Tutar; Deniz Ertem; Esin Kotiloglu Karaa; Ender Pehlivanoglu
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

10.  Investigation of regurgitation and other symptoms of gastroesophageal reflux in Indonesian infants.

Authors:  Badriul Hegar; Aswitha Boediarso; Agus Firmansyah; Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.